BioPharma Credit (LON:BPCP) Sets New 1-Year High – Still a Buy?

Shares of BioPharma Credit PLC (LON:BPCP – Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as GBX 75.40 and last traded at GBX 75.40, with a volume of 44,492 shares trading hands. The stock had previously closed at GBX 73.60.

BioPharma Credit Stock Down 1.2%

The stock’s 50 day moving average is GBX 73.07 and its two-hundred day moving average is GBX 71.33. The company has a market capitalization of £1.02 billion, a PE ratio of 11.01 and a beta of 0.18.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.